4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT)
Date du début: 1 nov. 2015, Date de fin: 30 avr. 2020,
RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis, that cause considerable mortality and morbidity, both from uncontrolled disease and treatment associated co-morbidities, like infection and malignancy. This requires the need to stratify patients b ...
Voir le projet
14
Participants partenaires
TERMINÉ
Disarming the intravascular innate immune response to improve treatment modalities for chronic kidney disease (DIREKT)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2017,
"Chronic kidney disease is world wide a major cause of end-stage renal disease (ESRD). 800.000 patients in Europe and in the US, respectively, require long-term treatment initially with peritoneal dialysis, followed by hemodialysis and kidney transplantation. Each ESRD patient on hemodialysis costs ≈€40000 to €80000 per year, has extremely poor quality of life and an average life expectancy of onl ...
Voir le projet
12
Participants partenaires
TERMINÉ
Infectious triggers of chronic autoimmunity (INTRICATE)
Date du début: 1 nov. 2010, Date de fin: 30 avr. 2015,
This proposal builds on existing expertise and collaborations of a multidisciplinary Consortium of basic scientists and clinical investigators each of whom has made a substantial individual contribution to understanding the links between infection and autoimmunity. The aim of the INTRICATE Consortium is to prosecute a programme of Translational Research that deliniates the role of infection in the ...
Voir le projet
13
Participants partenaires
TERMINÉ
Translational Science for Vascular Inflammation and Remodelling (TranSVIR)
Date du début: 1 déc. 2009, Date de fin: 30 nov. 2013,
The rapid advance of biology is providing new insights into the causes of some of today’s most pressing medical problems as well as huge opportunities to develop and evaluate novel and more effective treatments. The challenge is to exploit these advances effectively and this will require a new breed of translational scientist with expertise in a specific discipline coupled with a broad understandi ...
Voir le projet